Chronic Disease Flexible Coverage Act
Latest action · Mar 5, 2025 Received in the Senate and Read twice and referred to the Committee on Finance.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 4, 2025
- Passed HouseMar 4, 2025
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Chronic Disease Flexible Coverage Act
This bill provides statutory authority for guidance from the Internal Revenue Service (IRS) that expands the types of preventive care that may be offered under a high deductible health plan (HDHP) without requiring a deductible or with a deductible below the minimum threshold.
Under current law, to be considered health savings account-eligible, an HDHP must have a deductible above a certain minimum threshold amount, which is adjusted annually. However, an HDHP may cover certain types of preventive care without requiring a deductible or with a deductible below the minimum threshold.
The IRS issued guidance expanding the types of preventive care that may be covered by an HDHP without requiring a deductible or with a deductible below the minimum threshold to include
- angiotensin converting enzyme inhibitors for individuals with congestive heart failure, diabetes, or coronary artery disease;
- anti-resorptive therapy for individuals with osteoporosis or osteopenia;
- beta-blockers for individuals with congestive heart failure or coronary artery disease;
- blood pressure monitors for individuals with hypertension;
- inhaled corticosteroids and peak flow meters for individuals with asthma;
- insulin and other glucose lowering agents, retinopathy screening, glucometers, and hemoglobin A1c testing for individuals with diabetes;
- international normalized ratio testing for individuals with liver disease or bleeding disorders;
- low-density lipoprotein testing for individuals with heart disease;
- statins for individuals with heart disease or diabetes; and
- selective serotonin reuptake inhibitors for individuals with depression.
The bill provides statutory authority for the IRS's guidance.
Cosponsors 2
Members who signed on, in the order they did. Signatures ran from Feb 4, 2025 to Mar 3, 2025; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-CA | Jimmy Panetta | Original | Feb 4, 2025 |
| R-NY | Claudia Tenney | Mar 3, 2025 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Ways and Means Committee | Referred Feb 4, 2025 |
| Senate | Finance Committee | Referred Mar 5, 2025 |
Actions 8
Everything that happened, newest first.
- Mar 5, 2025Received in the Senate and Read twice and referred to the Committee on Finance.
- Mar 4, 2025Mr. Smith (MO) moved to suspend the rules and pass the bill.
- Mar 4, 2025Considered under suspension of the rules. (consideration: CR H964-966)
- Mar 4, 2025DEBATE - The House proceeded with forty minutes of debate on H.R. 919.
- Mar 4, 2025Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H964)
- Mar 4, 2025Motion to reconsider laid on the table Agreed to without objection.
- Feb 4, 2025Introduced in House
- Feb 4, 2025Referred to the House Committee on Ways and Means.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Debate and remarks H964–H966Text printed H964 | Gregory F. Murphy R-NC, Jason Smith R-MO, Jimmy Panetta D-CA, Vern Buchanan R-FL | Mar 4, 2025 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 171, no. 23, February 4, 2025, page H460.
Titles 5
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To codify Internal Revenue Service guidance relating to treatment of certain services and items for chronic conditions as meeting the preventive care deductible safe harbor for purposes of high deductible health plans in connection with health savings accounts.
- Short Title(s) as Introduced
- Chronic Disease Flexible Coverage Act
- Short Title(s) as Passed House
- Chronic Disease Flexible Coverage Act
- Short Titles from RFS (Referred to Senate) bill text
- Chronic Disease Flexible Coverage Act
- Official Title from EH (Engrossed in House) bill text
- To codify Internal Revenue Service guidance relating to treatment of certain services and items for chronic conditions as meeting the preventive care deductible safe harbor for purposes of high deductible health plans in connection with health savings accounts.
Subjects
Assigned by the Library of Congress. Policy area: Taxation.
Text 3
Each version as it was printed, newest first.
- Mar 5, 2025Referred in Senate
- Mar 4, 2025Engrossed in House
- Feb 4, 2025Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
